Catalyst Pharmaceuticals (CPRX) Change in Acquisitions & Divestments (2016 - 2022)
Catalyst Pharmaceuticals' Change in Acquisitions & Divestments history spans 8 years, with the latest figure at $9.9 million for Q3 2022.
- For Q3 2022, Change in Acquisitions & Divestments changed N/A year-over-year to $9.9 million; the TTM value through Dec 2022 reached $9.9 million, changed N/A, while the annual FY2022 figure was $19.2 million, N/A changed from the prior year.
- Change in Acquisitions & Divestments reached $9.9 million in Q3 2022 per CPRX's latest filing, up from $5.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $31.7 million in Q4 2019 to a low of $5.0 million in Q1 2020.
- Average Change in Acquisitions & Divestments over 4 years is $14.4 million, with a median of $10.0 million recorded in 2019.
- Peak YoY movement for Change in Acquisitions & Divestments: surged 122.95% in 2019, then crashed 75.49% in 2020.
- A 4-year view of Change in Acquisitions & Divestments shows it stood at $14.2 million in 2018, then soared by 122.95% to $31.7 million in 2019, then crashed by 84.21% to $5.0 million in 2020, then skyrocketed by 97.36% to $9.9 million in 2022.
- Per Business Quant, the three most recent readings for CPRX's Change in Acquisitions & Divestments are $9.9 million (Q3 2022), $5.0 million (Q1 2020), and $31.7 million (Q4 2019).